🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
0.4205
-0.0026 (-0.61%)
At close: Nov 18, 2026, 4:00 PM EST
0.4500
+0.0295 (7.02%)
After-hours: Nov 18, 2026, 7:30 PM EST

Telomir Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
3.238.110.012.370.020.01
Research & Development
2.462.442.241.570.830.13
Operating Expenses
5.6910.5412.243.940.850.14
Operating Income
-5.69-10.54-12.24-3.94-0.85-0.14
Interest Expense
-0--4.34-1.64--
Interest & Investment Income
0.210.130.05---
EBT Excluding Unusual Items
-5.48-10.41-16.53-5.59-0.85-0.14
Other Unusual Items
----7.49--
Pretax Income
-5.48-10.41-16.53-13.07-0.85-0.14
Net Income
-5.48-10.41-16.53-13.07-0.85-0.14
Net Income to Common
-51.59-10.41-16.53-13.07-0.85-0.14
Net Income Growth
------
Shares Outstanding (Basic)
4932302727-
Shares Outstanding (Diluted)
4932302727-
Shares Change
61.15%7.16%8.18%1.77%--
EPS (Basic)
-1.04-0.33-0.56-0.48-0.03-
EPS (Diluted)
-1.04-0.33-0.56-0.48-0.03-
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EBIT
-5.69-10.54-12.24-3.94-0.85-0.14
SEC Filings: 10-K · 10-Q